The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events

1998 ◽  
Vol 128 (4) ◽  
pp. 262 ◽  
Author(s):  
Howard N. Hodis
Reumatismo ◽  
2011 ◽  
Vol 59 (1) ◽  
Author(s):  
M. Carotti ◽  
F. Salaffi ◽  
M. Mangiacotti ◽  
A. Cerioni ◽  
G.M. Giuseppetti ◽  
...  

2000 ◽  
Vol 85 (8) ◽  
pp. 2793-2796 ◽  
Author(s):  
Hiroyuki Koshiyama ◽  
Yoshio Nakamura ◽  
Satsuki Tanaka ◽  
Jun Minamikawa

It has been suggested that bisphosphonates may have some antiatherogenic actions in experimental animals or in vitro, but their effects on the atherogenic process in humans has not been reported. In the present study the effect of etidronate treatment on carotid arterial intima-media thickness was prospectively examined in 57 subjects with type 2 diabetes associated with osteopenia. After 1 yr of therapy with cyclical etidronate (200 mg/day for 2 weeks every 3 months), intima-media thickness showed a decrease (mean ± se, −0.038 ± 0.011 mm), which was significantly different from a change in 57 control subjects (0.023 ± 0.015 mm; P < 0.005). Cardiovascular parameters were not changed after etidronate treatment. These findings suggest that etidronate in clinical dosage may have an antiatherogenic action, at least in type 2 diabetes, although its mechanisms remain to be elucidated.


2004 ◽  
Vol 19 (4) ◽  
Author(s):  
Tomoko Ishizu ◽  
Toshiyuki Ishimitsu ◽  
Hisako Yanagi ◽  
Yoshihiro Seo ◽  
Kenichi Obara ◽  
...  

2002 ◽  
Vol 17 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Tomoko Ishizu ◽  
T. Ishimitsu ◽  
Hideki Kamiya ◽  
Yoshihiro Seo ◽  
Naoko Moriyama ◽  
...  

2018 ◽  
Vol 18 (2) ◽  
pp. 252-260
Author(s):  
Manocher Iran-parvar ◽  
Hasan Anari ◽  
Seyed Taha Ghoreishi ◽  
Mohammad Javad Naghi-zadeh ◽  
SHadab Mirfakhrayi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document